Health
Life-extending drug for incurable breast cancer approved for NHS use – The Guardian
About 3,300 women a year may benefit from decision to approve ribociclib
Breast cancerAbout 3,300 women a year may benefit from decision to approve ribociclib
Fri 26 Feb 2021 08.57 EST
Women with incurable advanced breast cancer will be able to get a drug from the NHS that can potentially extend their life by almost eight months, under new guidance.
The National Institute for Health and Care Excellence (Nice) has approved the drug ribociclib , also known as Kisqali for routine use by the NHS in England and Wales. It said around 3,300 women a year with advanced breast…
-
General19 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
General17 hours agoHundreds attend justice march for Kaiden Morgan-Johnston in Morwell
-
Noosa News17 hours agoHow Roosters star Eliza Lopamaua found her way to NRLW
-
General12 hours agoNewcastle Jets defeat semi-professional Heidelberg United 3-1 to lift first Australia Cup